RESEARCH AND INNOVATION

Advancing sciencethrough research and innovation

Our company collaborates with world-leading experts to accelerate the translation of innovative technologies to support clinical management across the spectrum of disease, from metabolic disorders such as NAFLD and diabetes, to cancer.

CoverScan

Introducing CoverScan

The product of our latest research is CoverScan, a noninvasive imaging tool to assess the health of six organs using a single scan. We developed this product over a two-year journey working alongside our long COVID study community participants.  

This work has enabled us to assess multi-organ impairment in patients affected by long COVID and other conditions, whilst also investigating the inequalities in access  and provision of high-quality long COVID care.

Perspectum’s Prof. Sir Mike Brady and Dr. Rajarshi Banerjee are team members of the largest long COVID clinical study to-date — STIMULATE-ICP — led by University College London Hospitals NHS Trust and University College London, together with researchers, health professionals, patients, and industry partners from over 30 organizations.

LEARN MORE ABOUT COVERSCAN

Explore our research and innovation initiatives

newspapers

Publications

Explore our library of peer-reviewed clinical evidence, including our landmark paper on mpMRI as a predictive tool for clinical outcomes.

Learn more
research

Research projects

Explore our innovative solutions to the problems facing the healthcare sector and their patients.

Learn more

Recent Publications

Explore our library of peer-reviewed clinical evidence, including the recent publication in Open Heart, "Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection".

READ ROCA-FERNANDEZ ET AL.SEE ALL PUBLICATIONS